Evidence for Effectiveness

Size: px
Start display at page:

Download "Evidence for Effectiveness"

Transcription

1 Evidence for Effectiveness Developing a standards framework for digital health innovations Digitally empowering people to manage their health and care October 2018

2 The issue NHS England programmes Apps library - DAQs ITP/ITT Digital Diabetes programme Test Beds Innovation Landscape Review Literature review, workshops, interviews Clear requirement for consistent evidence standards Cycle of Pilots Little at scale implementation Emerging trust in digital health 2

3 The Problem The Goals How to demonstrate the impact of a digital health tool with appropriate evidence. Manufacturers are not clear what effectiveness and economic evidence they need to produce Commissioners are unclear what effectiveness and economic evidence they should be looking for A cycle of pilots and trials in the innovation space with little focus at scale implementation of such tools and value for money to the health and social care system. A trusted and respected source of advice on what evidence to produce; allowing innovators to produce better evidence, faster and more cost-effective, and in turn allow the NHS to commission, deploy and scale clinically and cost-effective digital health tools that meet demand. Related standards on how to produce evidence of effectiveness, economic impact and compliance with other standards. 3

4 Project Scope Type of digital health tools In Scope Digital health tools that are patient, citizen or clinician facing This will include mobile and web apps, wearables, digital therapeutics, VR/AR technology Apps that enable innovative value propositions and use of medical devices and diagnostics. Out of Scope Health IT systems True AI based digital tools the subject of a targeted initiative Conventional medical software required for the standard operation of a medical device or diagnostic. Type of evidence End goal of the advice Objective of the work Evidence to demonstrate clinical effectiveness Evidence to demonstrate behaviour change Evidence to demonstrate value for money and economic benefit To be commissioned or recommended by the NHS or its related health and care systems (e.g community clinics) and including social care Where applicable, to turn this advice into standards for future assessment to serve as a benchmark reference for innovators and commissioners To make easily accessible advice on how to generate evidence and why it matters Evidence of clinical safety Evidence that support security, data processing, technical stability Overseas market, lifestyle and wellbeing market To design the overall assessment framework for digital tools e.g. who will assess effectiveness and value for money in the system and when To review commissioning frameworks To design or build better infrastructure for 4 digital health research (NIHR)

5 Project Scope - what the project will and will not deliver Supporting evidence of effectiveness and economic impact Informing the assessment framework and process Evaluating individual tools 5

6 Project Milestones for developing Economic Standards July 18 Setting up project team and confirming scope of project Identify existing classification economic evaluation frameworks and establishing links with key stakeholders August 18 Developing a shared view of the conceptual approach to the economic standards. Sept 18 Host workshops with commissioners and innovators and develop content for digital tool Sept 18 Internal workshops with key advisors and project team Continue testing framework using and develop case studies that illustrate levels of evidence in the framework Oct - Nov 18 Workshops with wider set of stakeholders, innovators, academics, commissioners, ALBs, other key groups Dec - Jan 19 Development and launch of the support tool and standards Confirm arrangements for longer term maintenance 6

7 THE WIDER issue: innovation landscape review

8 A CODE OF CONDUCT principles and guidelines Real world feedback loop based on connected informative data sets 1 Idea 2 Standards 3 Evidence 4 Evaluation 5 Payment 6 Adoption Idea generation Does it meet the Standards? Evidence generation to show effectiveness Evaluation of ideas Payment and Commissioning Adoption by end users IDEA Code of Conduct For DHIs and Intelligent Algorithms ADOPTION, REGULATION AND EVIDENCE Digital Transformation Innovation landscape Review, Data led Policy, Value of Data HTA / Regulation / DAQs Commissioning, commercial and uptake WHAT THE CODE OF CONDUCT OFFERS 1. A clear set of principles and behaviours that creates a transparent and accountable environment for the development and deployment of trusted digital health innovations and intelligent algorithms within health and care. 2. Enable industry, academia, commissioners and individuals to easily identify the principles and guidelines of developing safe and effective products for the NHS. 3. Create a trusted set of products and innovations and a novel environment in health and care whereby we learn to base our policies on real world data and evidence thereby creating a unique framework to inform regulation. 8

9 Initial code of conduct for data-driven technologies Principle 9: Show evidence of effectiveness for the intended use You should provide evidence of how effective your product or innovation is for its intended use. If you are unable to show evidence, you should draw a plan that addresses the minimum required level of evidence given the functions performed by your technology...when building or developing the technology, consider what function the product delivers, and this will guide what sort of evidence generation plan should be put in place. The standards will also help the intended evaluation body review the package of evidence provided to them and help them outline gaps in the information they received from innovators Give feedback: 9

10 Who is involved? Project strategy & oversight Framework & Content Lead Comms & Integration Lead Evaluation Lead Innovation Lead AHSNs Lead Indra Joshi, NHS England Alexia Tonnel, Mark Salmon NICE Neelam Patel, MedCity Felix Greaves PHE Sam Roberts NHS England Axel Heitmeuller ICP, DH.L Executive Project Sponsors: Juliet Bauer, Chief Digital Officer, NHS England Simon Eccles, Chief Clinical Information Officer for Health and Care Gillian Leng Deputy Chief Executive, NICE 10

11 The framework in outline Standards for clinical effectiveness evidence - based on functional classification Standards for economic effectiveness evidence - based on budget impact Educational/signposting resources, Case studies 11

12 DRAFT Clinical effectiveness standards Functional classification Evidence standards 12

13 Tier 2 evidence requirements DHTs that provide information, simple monitoring or communication functions only Evidence categories Must have Minimum evidence standard Could have Best practice standard Technical standards The DHT must have passed assessment using the NHS Digital DAQ tool n/a Content Be able to demonstrate that the information contained in the DHT is valid (aligned to best available sources e.g. NICE guidance, relevant professional organisations or reputable patient organisations, and appropriate for the target population), accurate up to date Evidence of a documented information review and update cycle during the lifetime of the DHT Evidence of endorsement, accreditation or recommendation by NICE, NHSE, relevant professional organisation or reputable patient organisation Evidence that the information content has been validated though independent accreditation/certification such as The Information Standard or HONcode certification Clinical engagement in the design process Be able to demonstrate that there was relevant clinical input in the design, development and testing of the DHT Relevance Evidence to demonstrate that the information contained in the DHT is relevant to the UK health and care system Evidence to demonstrate the DHT has been successfully piloted in the UK health and social care system Ongoing data collection n/a Commitment to collect and report to commissioners on usage and outcomes (using non-patient identifiable information) to show ongoing value 13

14 Economic Impact Standards Concept Budget impact of the DHT* to health and social care sector Economic evidence standards *DHT = Digital Health Tool 14

15 Conceptual framework Calculate the budget impact of the DHT* Classify the budget impact (England) of the DHT into one of four categories Economic evidence standards described for each budget impact category * Using publicly-available tool which is part of the framework 15

16 Budget impact categories Budget impact category* Annual net cost for England s Health and Social Care System Cost saving Less than 0 Cost neutral Less than 1 million Low cost Between 1 million and 15 million High cost Greater than 15 million *Categories based on existing NICE resource impact categories for England. Assign budget impact category based on the maximum annual net cost. 16

17 Economic evidence standards National budget impact category Cost saving Economic evidence standard for individual DHTs Output(s) Cost neutral Budget impact calculation Budget impact figure ( ) Low cost Budget impact and cost consequence analysis Budget impact, costs and consequences (such as health and other related outcomes) in natural units High cost Budget impact and cost effectiveness analysis Budget impact, costs and health outcomes summarised in a single nonmonetary measure e.g. QALY to provide an incremental costeffectiveness ratio (ICER) 17

18 Early Adoption Feedback, concerns? Ideas on adopting framework into programmes Feedback and Iteration 18

Evidence Standards and AI

Evidence Standards and AI Evidence Standards and AI Dr Indra Joshi Digital Health and AI, Clinical Lead January 2019 We are creating a digital ecosystem that provides a consistent and trusted experience across digital tools and

More information

2. Evidence themes and their importance along the development path

2. Evidence themes and their importance along the development path 1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development

More information

IoT in Health and Social Care

IoT in Health and Social Care IoT in Health and Social Care Preserving Privacy: Good Practice Brief NOVEMBER 2017 Produced by Contents Introduction... 3 The DASH Project... 4 Why the Need for Guidelines?... 5 The Guidelines... 6 DASH

More information

The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet Clinical Commissioning Group

The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet Clinical Commissioning Group Meeting Health and Well-Being Board Date 27 June 2013 Subject Report of Summary of item and decision being sought The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet

More information

ABHI Response to the Kennedy short study on Valuing Innovation

ABHI Response to the Kennedy short study on Valuing Innovation ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.

More information

Digital Health Strategy

Digital Health Strategy Digital Health Strategy i3 Digital Health Strategy Digital health requires a change in mindset Purpose Drive a change in mindset towards engagement online Goal Exceptional and safe online behaviour and

More information

CCG Improvement and Assessment Framework 2016/17. Briefing Document

CCG Improvement and Assessment Framework 2016/17. Briefing Document CCG Improvement and Assessment Framework 2016/17 Briefing Document 4 th April 2016 Executive Summary NHS England has launched a new Improvement and Assessment Framework for Clinical Commissioning Groups

More information

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation Doing, supporting and using public health research The Public Health England strategy for research, development and innovation Draft - for consultation only About Public Health England Public Health England

More information

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Co-Design. Dr Louise Moody Coventry University Devices 4 Dignity, UK

Co-Design. Dr Louise Moody Coventry University Devices 4 Dignity, UK Co-Design Dr Louise Moody Coventry University Devices 4 Dignity, UK What is Devices 4 Dignity? D4D was set up in 2008 as one of two pilot Department of Health, Health Technology Cooperatives (HTCs) Funded

More information

Enfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Enfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2014 Summary report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of Clinical

More information

Sutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 36 o stakeholder survey 214 Summary report Version 1 Internal Use Only 13-98464-1 Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships

More information

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only CCG 360 o stakeholder survey 2014 Main report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of health and care

More information

Software as a Medical Device (SaMD)

Software as a Medical Device (SaMD) Software as a Medical Device () Working Group Status Application of Clinical Evaluation Working Group Chair: Bakul Patel Center for Devices and Radiological Health US Food and Drug Administration NWIE

More information

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results Slide 7 Using the results

More information

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Reflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation

Reflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation Reflection Paper on synergies between regulatory and HTA issues DG SANTE Unit B4 Medical products: safety, quality, innovation STAMP meeting, 28 June 2016 Outline Aim of the Reflection Paper Drafting process

More information

Innovation & health connected. Business plan summary

Innovation & health connected. Business plan summary Innovation & health connected Business plan summary 2017-18 CONTENTS Contents Introduction What do we do? Our five goals Goal 1: Transformation through innovation Goal 2: Economic growth Goal 3: Adoption

More information

December Eucomed HTA Position Paper UK support from ABHI

December Eucomed HTA Position Paper UK support from ABHI December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing

More information

Towards a Consumer-Driven Energy System

Towards a Consumer-Driven Energy System IEA Committee on Energy Research and Technology EXPERTS GROUP ON R&D PRIORITY-SETTING AND EVALUATION Towards a Consumer-Driven Energy System Understanding Human Behaviour Workshop Summary 12-13 October

More information

A review of the role and costs of clinical commissioning groups

A review of the role and costs of clinical commissioning groups A picture of the National Audit Office logo Report by the Comptroller and Auditor General NHS England A review of the role and costs of clinical commissioning groups HC 1783 SESSION 2017 2019 18 DECEMBER

More information

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey 1. Record Type? 2. Unique Number Reassessment R00423 3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey 4. Collection Type National 5. Other Reference 6. Description CCGs need to have strong relationships

More information

Human factors and design in future health care

Human factors and design in future health care Human factors and design in future health care Peter Buckle 1, Simon Walne 1, Simone Borsci 1,2 and Janet Anderson 3 1. NIHR London In Vitro Diagnostics Co-operative, Division of Surgery, Department of

More information

NHS and Social Care Innovation and Diffusion Challenges

NHS and Social Care Innovation and Diffusion Challenges NHS and Social Care Innovation and Diffusion Challenges NHS and Social Care Innovation and Diffusion Challenges Produced by mhabitat Contents Foreword 4 Introduction 6 Section 1 Mapping support available

More information

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD

More information

Horizon 2020 ICT Robotics Work Programme (draft - Publication: 20 October 2015)

Horizon 2020 ICT Robotics Work Programme (draft - Publication: 20 October 2015) NCP TRAINING BRUSSELS 07 OCTOBER 2015 1 Horizon 2020 ICT Robotics Work Programme 2016 2017 (draft - Publication: 20 October 2015) Cécile Huet Deputy Head of Unit Robotics Directorate General for Communication

More information

MRC Health and Biomedical Informatics Research Strategy

MRC Health and Biomedical Informatics Research Strategy MRC Health and Biomedical Informatics Research Strategy NHS-HE Forum 25th May 2016 Rhoswyn Walker Head of Informatics Research Medical Research in the Big Data Era Vast amount of biomedical and population

More information

Navigating the Healthcare Innovation Cycle

Navigating the Healthcare Innovation Cycle Navigating the Healthcare Innovation Cycle Introduction: CIMIT s 20 + years of experience in facilitating more than 600 projects is that innovation in Healthcare is a learnable, teachable process, which

More information

GPC update on co-commissioning of primary care: Important Guidance for CCG member practices and LMCs

GPC update on co-commissioning of primary care: Important Guidance for CCG member practices and LMCs GPC update on co-commissioning of primary care: Important Guidance for CCG member practices and LMCs This paper is to inform GP practices and LMCs about options for your CCG to take greater commissioning

More information

Compliance for Eucomed: The Medical Technology Industry s s Perspective

Compliance for Eucomed: The Medical Technology Industry s s Perspective Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big

More information

SHTG primary submission process

SHTG primary submission process Meeting date: 24 April 2014 Agenda item: 8 Paper number: SHTG 14-16 Title: Purpose: SHTG primary submission process FOR INFORMATION Background The purpose of this paper is to update SHTG members on developments

More information

Engaging UK Climate Service Providers a series of workshops in November 2014

Engaging UK Climate Service Providers a series of workshops in November 2014 Engaging UK Climate Service Providers a series of workshops in November 2014 Belfast, London, Edinburgh and Cardiff Four workshops were held during November 2014 to engage organisations (providers, purveyors

More information

Stage 2: eligibility screening. Stage 3: prioritisation. Stage 4: selection

Stage 2: eligibility screening. Stage 3: prioritisation. Stage 4: selection Digital therapy technology endorsement for IAPT project eligibility and prioritisation criteria NICE has been commissioned by NHS England to assess selected, digitally enabled therapies for depression

More information

Issues in Emerging Health Technologies Bulletin Process

Issues in Emerging Health Technologies Bulletin Process Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The

More information

NIHR ROADSHOW FOR MEDTECH SMES

NIHR ROADSHOW FOR MEDTECH SMES MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and

More information

DEPARTMENT OF COMMUNICATIONS. No April 2013 MINISTER OF COMMUNICATIONS OUTLINE OF THE ICT POLICY REVIEW PROCESS, 2013

DEPARTMENT OF COMMUNICATIONS. No April 2013 MINISTER OF COMMUNICATIONS OUTLINE OF THE ICT POLICY REVIEW PROCESS, 2013 STAATSKOERANT, 10 APRIL 2013 No. 36359 3 GOVERNMENT NOTICE DEPARTMENT OF COMMUNICATIONS No. 277 10 April 2013 MINISTER OF COMMUNICATIONS OUTLINE OF THE ICT POLICY REVIEW PROCESS, 2013 In April 2012, the

More information

EMA experience with the review of digital technology proposals in medicine development programmes

EMA experience with the review of digital technology proposals in medicine development programmes EMA experience with the review of digital technology proposals in medicine development programmes 3rd Industry Stakeholder Platform on R&D support, 18 May 2018 Francesca Cerreta, Scientific Advice An agency

More information

Technology and Innovation in the NHS Highlands and Islands Enterprise

Technology and Innovation in the NHS Highlands and Islands Enterprise Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise

More information

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence ICDPPC declaration on ethics and data protection in artificial intelligence AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issues. It aims to ensure

More information

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,

More information

Digitisation Plan

Digitisation Plan Digitisation Plan 2016-2020 University of Sydney Library University of Sydney Library Digitisation Plan 2016-2020 Mission The University of Sydney Library Digitisation Plan 2016-20 sets out the aim and

More information

Centre for Healthcare Technologies

Centre for Healthcare Technologies Centre for Healthcare Technologies Steve Morgan www.healthcaretechnologies.ac.uk Launched 29.2.16 The future: doom and gloom? 2011 2015 Healthcare Public Patients Clinicians Policy RCUK Regulators NHS

More information

The Industrial Strategy Challenge Fund

The Industrial Strategy Challenge Fund The Industrial Strategy Challenge Fund Mike Biddle Programme Director Industrial Strategy Challenge Fund @Mike_Biddle Harwell - 28 th November 2017 (v4) [Official] Overview 1. Industrial Strategy & the

More information

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer 13 December 2007 A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer Project Team Leela Barham Michelle Ng NERA Economic Consulting 15 Stratford Place London W1C 1BE United Kingdom Tel:

More information

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 The Challenge Our ambition must be for an NHS defined by its commitment

More information

Safety related product corrective action

Safety related product corrective action Safety related product corrective action Brian Such Standards Solutions Project Manager British Standards Institution Copyright 2017 BSI. All rights reserved 1 03/07/2017 Safety related product corrective

More information

Parkinson s World A transformational project by The Cure Parkinson s Trust

Parkinson s World A transformational project by The Cure Parkinson s Trust Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication

More information

NHS Next Stage Review: Innovation

NHS Next Stage Review: Innovation NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused

More information

NHS HMR CCG and NHS England Primary Care Joint Commissioning Committee 2015/16

NHS HMR CCG and NHS England Primary Care Joint Commissioning Committee 2015/16 NHS HMR CCG and NHS England Primary Care Joint Commissioning Committee 2015/16 Date of Meeting: 15 September 2015 Agenda Item: 14 Subject: CCG Assurance New Operating Model Reporting Officer: Sandra Croasdale

More information

GOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2

GOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2 GOVERNING BODY MEETING in Public 25 April 2018 Paper Title Paper Author(s) Jerry Hawker Accountable Officer NHS Eastern Cheshire CCG The Future of CCG Commissioning in Cheshire Alison Lee Accountable Officer

More information

Copyright: Conference website: Date deposited:

Copyright: Conference website: Date deposited: Coleman M, Ferguson A, Hanson G, Blythe PT. Deriving transport benefits from Big Data and the Internet of Things in Smart Cities. In: 12th Intelligent Transport Systems European Congress 2017. 2017, Strasbourg,

More information

EGIDA Project The EGIDA Methodology P. Mazzetti (CNR-IIA) Istanbul, Turkey November, 2011

EGIDA Project The EGIDA Methodology P. Mazzetti (CNR-IIA) Istanbul, Turkey November, 2011 EGIDA Project The EGIDA Methodology P. Mazzetti (CNR-IIA) Istanbul, Turkey November, 2011 Outline Design of the EGIDA Methodology Description of the EGIDA Methodology DESIGN OF THE EGIDA METHODOLOGY Rationale

More information

e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)

e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0) e-care Living Lab e-care Living Lab in Rhône-Alpes Region e-care got the Living Lab label in 2010 from ENoLL e-care Living Lab objectives (1/2) To promote the Living Lab approach in the healthcare sector

More information

The Information Commissioner s response to the Draft AI Ethics Guidelines of the High-Level Expert Group on Artificial Intelligence

The Information Commissioner s response to the Draft AI Ethics Guidelines of the High-Level Expert Group on Artificial Intelligence Wycliffe House, Water Lane, Wilmslow, Cheshire, SK9 5AF T. 0303 123 1113 F. 01625 524510 www.ico.org.uk The Information Commissioner s response to the Draft AI Ethics Guidelines of the High-Level Expert

More information

LIVING LAB OF GLOBAL CHANGE RESEARCH

LIVING LAB OF GLOBAL CHANGE RESEARCH LIVING LAB OF GLOBAL CHANGE RESEARCH PhD Tanja Suni, Secretary General Future Earth Finland www.futureearthfinland.fi OUTLINE Our pilot Answers to session questions Lessons learned IMPROVING UTILISATION

More information

Dr George Gillespie. CEO HORIBA MIRA Ltd. Sponsors

Dr George Gillespie. CEO HORIBA MIRA Ltd. Sponsors Dr George Gillespie CEO HORIBA MIRA Ltd Sponsors Intelligent Connected Vehicle Roadmap George Gillespie September 2017 www.automotivecouncil.co.uk ICV Roadmap built on Travellers Needs study plus extensive

More information

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

25 th Workshop of the EURORDIS Round Table of Companies (ERTC) 25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00

More information

Horizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper

Horizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper VTT TECHNICAL RESEARCH CENTRE OF FINLAND LTD Horizon Scanning Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper Principal Scientist in Business, Innovation and Foresight VTT Technical Research

More information

Health & Social Care Industrial Innovation

Health & Social Care Industrial Innovation Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging

More information

Accountable Officer Report

Accountable Officer Report Accountable Officer Report 1. CCG Annual Report and Annual Public Meeting At its 24 May 2018 meeting, in line with delegated responsibilities, the Audit and Governance Committee approved the CCG s Annual

More information

Hints & Tips: NIHR Evaluation Trials & Studies Coordinating Centre (NETSCC) Funding Opportunities for Northern Ireland

Hints & Tips: NIHR Evaluation Trials & Studies Coordinating Centre (NETSCC) Funding Opportunities for Northern Ireland Hints & Tips: NIHR Evaluation Trials & Studies Coordinating Centre (NETSCC) Funding Opportunities for Northern Ireland Janice Bailie HSC R&D Division Public Health Agency How to Secure NIHR Funding: NETS

More information

Digital Health and Introducing Innovative Technologies in the NHS

Digital Health and Introducing Innovative Technologies in the NHS Digital Health and Introducing Innovative Technologies in the NHS 22 September 2015 NATIONAL INFORMATION BOARD techuk.org @techuk #techuk Digital Health and introducing innovative technologies in the NHS

More information

Supporting Innovation through Regulation and Science

Supporting Innovation through Regulation and Science Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers

More information

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry

More information

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell

More information

Medical Education Activities

Medical Education Activities Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time

More information

SMART PLACES WHAT. WHY. HOW.

SMART PLACES WHAT. WHY. HOW. SMART PLACES WHAT. WHY. HOW. @adambeckurban @smartcitiesanz We envision a world where digital technology, data, and intelligent design have been harnessed to create smart, sustainable cities with highquality

More information

Herts Valleys Clinical Commissioning Group. Review of NHS Herts Valleys CCG Constitution

Herts Valleys Clinical Commissioning Group. Review of NHS Herts Valleys CCG Constitution Herts Valleys Clinical Commissioning Group Review of NHS Herts Valleys CCG s constitution Agenda Item: 14 REPORT TO: HVCCG Board DATE of MEETING: 30 January 2014 SUBJECT: Review of NHS Herts Valleys CCG

More information

The British Food Plan

The British Food Plan 23/05/2014 The British Food Plan Enabling a healthy future for our people, farms and food producers Dr Peter Bonfield OBE FREng Independent Chair, British Food Plan Learning from London 2012 1 3 2 Public

More information

3b. Definition of Readiness: Update on Readiness Package and FCPF/UN-REDD Collaboration

3b. Definition of Readiness: Update on Readiness Package and FCPF/UN-REDD Collaboration 3b. Definition of Readiness: Update on Readiness Package and FCPF/UN-REDD Collaboration Joint Meeting between the UN-REDD Policy Board and FCPF Participants Committee Asunción, Paraguay March 27, 2012

More information

Health Innovation Manchester

Health Innovation Manchester Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing

More information

AI in Europe How could the EC help European society and economy to make the best of this revolution?

AI in Europe How could the EC help European society and economy to make the best of this revolution? AI in Europe How could the EC help European society and economy to make the best of this revolution? => H2020 - ICT-26-2018-2020 Artificial Intelligence Cécile Huet, PhD Deputy Head of Unit A1 Robotics

More information

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Health Innovations in Horizon 2020: the framework programme for research and innovation ( ) Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General

More information

NIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators

NIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators NIHR / Wellcome Trust King s Clinical Research Facility Guidance for Investigators Introduction The NIHR Clinical Research Facilities provide dedicated facilities to support the delivery of externally-funded

More information

Human Rights Risk Tool for Seafood. Helen Duggan, Head of Responsible Sourcing, Seafish

Human Rights Risk Tool for Seafood. Helen Duggan, Head of Responsible Sourcing, Seafish Human Rights Risk Tool for Seafood Helen Duggan, Head of Responsible Sourcing, Seafish Seafood Human Rights Risk Tool Collaboration to develop one risk assessment approach Identify and assess the risk

More information

Title: care.data Pathfinder Stage CCG Recruitment and Selection Process

Title: care.data Pathfinder Stage CCG Recruitment and Selection Process Ref: care.data/programme Board/Paper 06 Title: care.data Pathfinder Stage CCG Recruitment and Selection Process Author: David Corbett, Programme Head, Data Delivery Programme Board Sponsor: Eve Roodhouse,

More information

Innovationen gemeinsam entwickeln und umsetzen

Innovationen gemeinsam entwickeln und umsetzen Keynote: Artificial intelligence in the public sector. Applications, scenarios, use Innovationen gemeinsam entwickeln und umsetzen Victor de la Torre, Senior Research Fellow, Fujitsu Human Centric Innovation

More information

Consultancy on Technological Foresight

Consultancy on Technological Foresight Consultancy on Technological Foresight A Product of the Technical Cooperation Agreement Strategic Roadmap for Productive Development in Trinidad and Tobago Policy Links, IfM Education and Consultancy Services

More information

Implementation of Systems Medicine across Europe

Implementation of Systems Medicine across Europe THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0 The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation

More information

Research Development Request - Profile Template. European Commission

Research Development Request - Profile Template. European Commission Research Development Request - Profile Template European Commission Research Development Request Profile The following table can be used as a template for drafting a Research Development Request profile.

More information

The Potential Social and Economic Value of Innovation Procurement

The Potential Social and Economic Value of Innovation Procurement The Potential Social and Economic Value of Innovation Procurement Dr. Gabriela Prada Director, Health Innovation, Policy and Evaluation Healthcare Efficiency Conference September 19 th, 2011 Overview About

More information

Maturity Model for Integrated Care Dr Andrea Pavlickova NHS 24, Scotland

Maturity Model for Integrated Care Dr Andrea Pavlickova NHS 24, Scotland @ SCIROCCO_EU Maturity Model for Integrated Care Dr Andrea Pavlickova NHS 24, Scotland 6 th Training School: Upscaling & Mainstreaming Guidelines, Crete @ SCIROCCO_EU Scaling-up Integrated Care In Europe

More information

WHO Regulatory Systems Strengthening Program

WHO Regulatory Systems Strengthening Program WHO Regulatory Systems Strengthening Program MVP RHT RSS CRS www.who.int Minimal capacity met Eligibility for vaccine PQ WHO listed NRAs WHO NRA 5 step capacity building Development of NRA benchmarking

More information

Helping your business grow in the UK health system

Helping your business grow in the UK health system Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain

More information

Enabling ICT for. development

Enabling ICT for. development Enabling ICT for development Interview with Dr M-H Carolyn Nguyen, who explains why governments need to start thinking seriously about how to leverage ICT for their development goals, and why an appropriate

More information

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints

More information

A Roadmap for Connected & Autonomous Vehicles. David Skipp Ford Motor Company

A Roadmap for Connected & Autonomous Vehicles. David Skipp Ford Motor Company A Roadmap for Connected & Autonomous Vehicles David Skipp Ford Motor Company ! Why does an Autonomous Vehicle need a roadmap? Where might the roadmap take us? What should we focus on next? Why does an

More information

Gender pay gap reporting tight for time

Gender pay gap reporting tight for time People Advisory Services Gender pay gap reporting tight for time March 2018 Contents Introduction 01 Insights into emerging market practice 02 Timing of reporting 02 What do employers tell us about their

More information

ANZPAA National Institute of Forensic Science BUSINESS PLAN

ANZPAA National Institute of Forensic Science BUSINESS PLAN ANZPAA National Institute of Forensic Science BUSINESS PLAN 2016 2017 OUR STRATEGIC INTENT PROMOTE AND FACILITATE EXCELLENCE IN FORENSIC SCIENCE The National Institute of Forensic Science is a directorate

More information

UK High-Field NMR Funding and the UKRI Infrastructure Roadmap

UK High-Field NMR Funding and the UKRI Infrastructure Roadmap UK High-Field NMR Funding and the UKRI Infrastructure Roadmap Tony Chapman, EPSRC UK NMR Manager s Meeting University of Warwick 20 th June 2018 Topics to be covered today Part 1- An overview of UK investment

More information

Science for Policy. Impact of Social Sciences & Humanities. David Mair (chair) Antti Pelkonen Mihiri Seneviratne. Gemyse 1,

Science for Policy. Impact of Social Sciences & Humanities. David Mair (chair) Antti Pelkonen Mihiri Seneviratne. Gemyse 1, Impact of Social Sciences & Humanities Gemyse 1, 11.30-12.45 4-5 October 2018, Copenhagen Science for Policy David Mair (chair) Antti Pelkonen Mihiri Seneviratne Impact of Social Sciences & Humanities

More information

National Workshop on Responsible Research & Innovation in Australia 7 February 2017, Canberra

National Workshop on Responsible Research & Innovation in Australia 7 February 2017, Canberra National Workshop on Responsible & Innovation in Australia 7 February 2017, Canberra Executive Summary Australia s national workshop on Responsible and Innovation (RRI) was held on February 7, 2017 in

More information

Andalusian Agency for Health Technology Assessment (AETSA)

Andalusian Agency for Health Technology Assessment (AETSA) Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction

More information

"I and my Ministerial colleagues recognise the imperative and opportunity to see more co-production in the design and delivery of public services.

I and my Ministerial colleagues recognise the imperative and opportunity to see more co-production in the design and delivery of public services. In Primary Care? "I and my Ministerial colleagues recognise the imperative and opportunity to see more co-production in the design and delivery of public services. First Minister Carwyn Jones " co-production

More information

Dr Andrea Pavlickova NHS 24, Scotland

Dr Andrea Pavlickova NHS 24, Scotland Maturity Model for Integrated Care Dr Andrea Pavlickova NHS 24, Scotland 6 th Training School: Upscaling & Mainstreaming Guidelines 5 October 2016, Crete Scaling-up Integrated Care In Europe Integrated

More information

WG/STAIR. Knut Blind, STAIR Chairman

WG/STAIR. Knut Blind, STAIR Chairman WG/STAIR Title: Source: The Operationalisation of the Integrated Approach: Submission of STAIR to the Consultation of the Green Paper From Challenges to Opportunities: Towards a Common Strategic Framework

More information

Innovative Approaches in Collaborative Planning

Innovative Approaches in Collaborative Planning Innovative Approaches in Collaborative Planning Lessons Learned from Public and Private Sector Roadmaps Jack Eisenhauer Senior Vice President September 17, 2009 Ross Brindle Program Director Energetics

More information